» Articles » PMID: 26816275

Pathophysiology and Pathomorphology of Osteoporosis

Overview
Date 2016 Jan 28
PMID 26816275
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Osteoporosis is a disease that leads to fragility fractures due to the loss of bone mass and bone microstructure. This review presents an update on the fundamental pathophysiological and pathomorphological mechanisms of bone loss. Pathomorphological characteristics such as perforations and microcallus formations are explained. The physiological relevance of the remodeling process and its control by local paracrine, systemic endocrine, and central neural signaling pathways are discussed. Hormones, such as estrogen, follicle stimulating hormone, and leptin, transcription factors, such as Runx2 and osterix, and the wnt signaling pathway are discussed in terms of their roles in bone cell differentiation and function. On the basis of current knowledge, osteoporosis can be diagnosed and treated and fractures can be prevented. However, it is likely that new and even more effective diagnostic and therapeutic strategies will emerge as our understanding of the remodeling process that controls osteoblast and osteoclast function increases.

Citing Articles

Relationship between osteoporosis and expression of Bcl-2 and CXCL12.

Pang T, Gong M, Han J, Liu D Exp Ther Med. 2018; 15(2):1293-1297.

PMID: 29434715 PMC: 5774382. DOI: 10.3892/etm.2017.5513.


Osteoblast Role in Rheumatic Diseases.

Corrado A, Maruotti N, Cantatore F Int J Mol Sci. 2017; 18(6).

PMID: 28617323 PMC: 5486094. DOI: 10.3390/ijms18061272.


Focus on Skeletal Bone Diseases - Osteoporosis and Paget's Disease of Bone.

Eur J Trauma Emerg Surg. 2016; 34(6):525.

PMID: 26816274 DOI: 10.1007/s00068-008-1006-1.

References
1.
Grant A, Avenell A, Campbell M, McDonald A, MacLennan G, McPherson G . Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet. 2005; 365(9471):1621-8. DOI: 10.1016/S0140-6736(05)63013-9. View

2.
Sun L, Peng Y, Sharrow A, Iqbal J, Zhang Z, Papachristou D . FSH directly regulates bone mass. Cell. 2006; 125(2):247-60. DOI: 10.1016/j.cell.2006.01.051. View

3.
Lips P . Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001; 22(4):477-501. DOI: 10.1210/edrv.22.4.0437. View

4.
Gong Y, Slee R, Fukai N, Rawadi G, Roman-Roman S, Reginato A . LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell. 2001; 107(4):513-23. DOI: 10.1016/s0092-8674(01)00571-2. View

5.
Teitelbaum S . Bone resorption by osteoclasts. Science. 2000; 289(5484):1504-8. DOI: 10.1126/science.289.5484.1504. View